ProMIS Neurosciences

D

Quotes are delayed by 15 minutes

Sector: Healthcare

Industry: Biotechnology

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMISand Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.